Methimazole (Tapazole) Cost in Maine 2026

What Does Methimazole (Tapazole) Actually Cost in Maine?

Maine residents paying cash for methimazole in 2026 typically spend around $15 per month at retail pharmacies, according to aggregated pharmacy pricing data. The branded Tapazole carries a manufacturer list price near $80 per month, but generic methimazole captures the overwhelming majority of fills. Applying a free GoodRx or similar coupon at most Maine pharmacies drops the 30-tablet supply of 10 mg methimazole to between $9 and $22 depending on location and dispensing pharmacy.

Generic methimazole became widely available after the original Tapazole patent expired, and the FDA maintains a current list of approved generic manufacturers on its Orange Book [1]. The practical result for most Maine patients: branded Tapazole pricing is largely irrelevant unless a prescriber writes "dispense as written" and the plan specifically requires the brand.

Dose affects cost directly. The NEJM landmark trial by Cooper et al. (2005) established that methimazole dosed at 20 to 30 mg daily achieves euthyroidism in most patients with Graves hyperthyroidism within 6 to 8 weeks, after which doses are titrated down to 5 to 10 mg daily for maintenance [2]. A patient stabilized on 5 mg once daily will pay less per month than one on 30 mg in divided doses. Confirm your maintenance dose with your prescriber before comparing pharmacy quotes.

Prices also vary across Maine's geography. Pharmacies in Portland and Bangor tend to be more competitive on cash pricing than independent pharmacies in rural Aroostook County, where supply chain overhead raises costs modestly. Always call ahead or use an online coupon-checker with your specific zip code.

Pfizer manufactures the branded Tapazole and offers a manufacturer savings card program; details are available directly through their patient assistance portal [3]. Eligible commercially insured patients may pay as little as $0 per month on brand, though most prescribers default to generics and most plans actively substitute them.

Does Maine Medicaid (MaineCare) Cover Methimazole?

MaineCare covers methimazole for hyperthyroidism and Graves disease, but a prior authorization (PA) is required before the claim will process [4]. The PA requirement exists because Maine's Preferred Drug List (PDL) designates methimazole as a covered thyroid agent subject to utilization management. Without an approved PA on file, the pharmacy will reject the claim and the patient pays cash.

Getting the PA approved is straightforward in most cases. The prescriber submits documentation of a confirmed hyperthyroid diagnosis, typically a suppressed TSH below 0.4 mIU/L combined with elevated free T4 or free T3, along with the intended dose and duration. The American Thyroid Association's 2016 guidelines on hyperthyroidism management support antithyroid drug therapy as first-line treatment for most patients with Graves disease, which gives prescribers a strong evidence base to cite in PA submissions [5].

Once approved, a MaineCare member's cost-sharing for methimazole is minimal, usually $1, $4 per fill depending on their specific benefit plan. Dual-eligible patients (Medicare and Medicaid) may have the cost covered entirely. If your PA is denied on first submission, Maine law provides an expedited appeals process; your prescriber's office can typically file a peer-to-peer review within 72 hours.

Maine expanded Medicaid under the Affordable Care Act in 2019, adding roughly 90,000 enrollees. Adults with incomes up to 138% of the federal poverty level qualify. The Maine Department of Health and Human Services publishes current PDL updates at its official site [4].

Is Compounded Methimazole Legal in Maine?

Compounded methimazole from a licensed 503A pharmacy is legal in Maine and can reduce patient cost to near zero in certain clinical situations [6]. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed compounding pharmacies to prepare patient-specific preparations when a valid prescriber-patient relationship exists and a legitimate clinical need is documented.

Maine's Board of Pharmacy licenses and inspects 503A pharmacies operating within the state. A compounded preparation requires a prescription written for an individual patient; bulk compounding for resale without a prescription is not permitted under 503A. The FDA's guidance on 503A compounding lays out the requirements in detail [6].

Clinically, compounded methimazole is most relevant when a patient cannot tolerate commercially available tablet strengths, requires a dose not easily achieved by splitting tablets, or needs an alternative delivery form such as a transdermal gel for pediatric patients or those with severe nausea. The standard commercial tablets come in 5 mg and 10 mg strengths; doses of 2.5 mg or 7.5 mg require compounding or tablet splitting.

Cost to the patient from a 503A compounding pharmacy in Maine may be $0 per month when insurance covers the compounded preparation or when the pharmacy offers a patient-assistance price. Cash prices vary by compound complexity. Ask your compounding pharmacy for an itemized quote and verify that the pharmacy holds a current Maine Board of Pharmacy license before filling [7].

One caution: not all insurance plans, including some MaineCare managed care organizations, cover compounded preparations. Verify coverage before switching from a commercial tablet.

Can You Get a Methimazole Prescription via Telehealth in Maine?

Yes. Maine law permits telehealth prescribing of methimazole, and the state's telehealth statute does not restrict Schedule IV or V compounds differently from non-controlled medications [8]. Methimazole is not a controlled substance, so none of the DEA's telehealth restrictions on controlled substances apply.

A telehealth provider licensed in Maine can evaluate a patient via synchronous audio-video visit, review lab results including TSH, free T4, and free T3, and issue a prescription for methimazole without an in-person visit. The Maine Medical Association and the Maine Legislature aligned state telehealth rules with the federal 2020 telehealth expansion policies; these rules remained intact through 2025 [8].

HealthRX operates under these same rules. Our board-certified clinicians review thyroid labs, assess symptom burden, and issue or refill methimazole prescriptions for Maine residents entirely via telehealth. The prescription routes electronically to any Maine pharmacy or to a 503A compounding pharmacy of the patient's choice.

Lab monitoring still applies. Cooper et al. (NEJM 2005) noted that complete blood count monitoring is necessary given the risk of agranulocytosis, a rare but serious adverse effect occurring in approximately 0.1 to 0.5% of patients, most commonly within the first 90 days of therapy [2]. Telehealth providers must ensure patients have access to a local lab for monitoring draws. Most Maine hospitals and LabCorp or Quest locations serve this need.

Which Insurance Plans Cover Methimazole in Maine?

Nearly every commercial insurance plan sold in Maine covers generic methimazole, typically on Tier 1 or Tier 2 of the formulary. Tier 1 copays in Maine range from $0 to $15 per 30-day supply on most ACA marketplace plans, employer-sponsored plans, and Medicare Part D plans. Branded Tapazole, when covered, usually sits on Tier 3 or higher with copays of $30, $60 or more.

Medicare Part D covers methimazole across virtually all standalone Part D plans available in Maine. The 2026 Medicare Part D redesign capped out-of-pocket drug spending at $2,000 annually, so even higher-cost scenarios are bounded [9]. For methimazole at $15/month cash price, Part D coverage translates to negligible cost-sharing for most beneficiaries.

ACA marketplace plans sold through CoverME.gov, Maine's state-based exchange, must cover prescription drugs as an essential health benefit. All silver, gold, and platinum plans are required to include thyroid medications on formulary [10]. Bronze plans technically meet the standard with higher cost-sharing; review your specific plan's drug tier table before enrolling.

Employer self-insured plans (governed by ERISA) are not subject to Maine state insurance mandates but typically mirror commercial plan formularies. If your employer plan excludes methimazole, a formal exception request citing medical necessity is usually sufficient given the drug's low cost and clinical necessity for thyroid disease.

How to Get the Cheapest Methimazole Price in Maine: A Step-by-Step Framework

Getting the lowest out-of-pocket cost depends on which payer category applies to you. The following framework organizes the options by coverage status.

Uninsured or underinsured patients. Start by checking GoodRx, RxSaver, and Cost Plus Drugs (Mark Cuban's pharmacy) for your specific dose and the Maine zip code of your preferred pharmacy. In 2026, Cost Plus Drugs lists methimazole 10 mg (90 tablets) for under $10 including markup and dispensing fee [11]. GoodRx coupons at Walmart, Hannaford Pharmacy, and Rite Aid locations in Maine typically land between $9 and $18 for a 30-day supply. Print or download the coupon before presenting at the counter; pharmacy staff cannot apply it after the transaction is processed.

MaineCare enrollees. Confirm your PA status with your prescriber's office before the first fill. If a PA has not been submitted, ask the office to file one citing your TSH and free T4 values plus the ATA guideline reference [5]. Average time to PA approval through MaineCare is 3, 5 business days for non-urgent requests.

Commercially insured patients. Ask your pharmacy to run the claim under your insurance first, then compare the insured copay to a GoodRx price. Pharmacists are not always required to disclose which is lower; ask explicitly. On some plans, the GoodRx cash price is cheaper than the Tier 1 copay, but you cannot apply both simultaneously.

Medicare Part D enrollees. Contact your plan's member services line to confirm methimazole's tier status for 2026 before your plan year begins. If the drug moved to a higher tier, file a formulary exception citing the ATA guidelines [5] and your prescriber's letter of medical necessity.

Patients with severe nausea or dosing challenges. Ask your prescriber whether a 503A compounded preparation is appropriate. Contact a Maine-licensed compounding pharmacy for a quote, and verify whether your plan covers compounded thyroid preparations.

Methimazole Dosing, Monitoring, and Clinical Context for Maine Patients

Methimazole inhibits thyroid peroxidase, blocking the synthesis of T3 and T4. It does not destroy existing thyroid hormone stores, so symptomatic relief typically begins within 1 to 2 weeks as circulating T3 and T4 are cleared, while TSH normalization requires 4 to 8 weeks in most patients [2].

The FDA-approved label for methimazole specifies an initial adult dose of 15 mg daily for mild hyperthyroidism, 30 to 40 mg daily for moderate to severe disease, and up to 60 mg daily in severe cases, all in divided doses [12]. After the patient achieves euthyroid status, the prescriber titrates to the lowest effective maintenance dose, typically 5 to 10 mg once daily. This maintenance phase can last 12 to 18 months for Graves disease; approximately 50% of patients achieve remission after a full course, according to the ATA [5].

Monitoring requirements add modest ancillary costs for Maine patients. A baseline CBC and liver function panel before starting therapy is standard practice. Repeat CBC is recommended if a patient develops fever, sore throat, or mouth ulcers, given the agranulocytosis risk described above [2]. TSH and free T4 checks every 4 to 8 weeks during dose titration are typical, then every 3 to 6 months during stable maintenance. Quest Diagnostics and LabCorp both operate patient service centers in Portland, Bangor, Lewiston, and other Maine cities; most tests are covered under standard insurance.

Propylthiouracil (PTU) is the alternative antithyroid drug used when methimazole is contraindicated, most notably in the first trimester of pregnancy. The ATA guidelines state clearly: "Methimazole is the preferred antithyroid drug in patients who are not in the first trimester of pregnancy" [5]. PTU carries a higher risk of serious hepatotoxicity; the FDA added a black-box warning to PTU in 2010 [13]. This risk comparison directly supports methimazole as the default choice for non-pregnant adults in Maine and nationally.

Methimazole Side Effects and Safety Considerations

The most clinically significant adverse effects are agranulocytosis (0.1 to 0.5% incidence), hepatocellular injury (rare), and cutaneous reactions including rash and urticaria (approximately 5% incidence) [2]. Minor rash can sometimes be managed with antihistamines without stopping the drug; severe rash, jaundice, or any fever with sore throat requires immediate discontinuation and CBC measurement.

Methimazole crosses the placenta and can affect fetal thyroid development. Women of childbearing age should discuss contraception planning with their provider. If pregnancy occurs during methimazole therapy, prompt switching to PTU for the first trimester, then reassessment, is the accepted protocol per the Endocrine Society's clinical practice guideline on thyroid disease in pregnancy [14].

Drug interactions are limited but include warfarin (methimazole may potentiate anticoagulant effects by reducing vitamin K-dependent clotting factor synthesis as hyperthyroidism is corrected) and digoxin (euthyroid state changes volume of distribution) [12]. Prescribers should review the full interaction list in the FDA label before initiating therapy in patients on anticoagulants or narrow therapeutic index drugs.

Finding a Maine Provider Who Prescribes Methimazole

Endocrinologists, internal medicine physicians, family medicine physicians, and advanced practice providers with thyroid experience all prescribe methimazole in Maine. The Maine Endocrinology practice at Maine Medical Center in Portland and Eastern Maine Medical Center's endocrinology division in Bangor are two established in-person options. Wait times for new endocrinology patients in Maine can run 3 to 6 months.

Telehealth closes that gap. Patients with lab-confirmed hyperthyroidism can often be evaluated and prescribed within 24 to 48 hours through platforms like HealthRX. The Maine telehealth statute requires the provider to hold a Maine license or qualify under the interstate medical licensure compact [8]. Verify licensure before your first visit.

If your primary care provider is comfortable managing hyperthyroidism, that is a reasonable path. The ATA and American Association of Clinical Endocrinology (AACE) both publish management guidelines accessible to generalists [5][15]. Primary care management works well for straightforward Graves disease with no ophthalmopathy or severe disease features.